Hillsdale Investment Management Inc. Edwards Lifesciences Corp Transaction History

Hillsdale Investment Management Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$68.3 - $87.44 $13,660 - $17,488	-200 Reduced 3.77%	5,100 $380,000
Q2 2022 Aug 12, 2022	BUY	$86.5 - $128.27 $8,650 - $12,827	100 Added 1.92%	5,300 $505,000
Q1 2022 Apr 28, 2022	SELL	$101.96 - $128.34 $50,980 - $64,170	-500 Reduced 8.77%	5,200 $612,000
Q2 2021 Jul 29, 2021	BUY	$83.84 - $104.76 $477,888 - $597,132	5,700 New	5,700 $590,000
Q3 2020 Nov 13, 2020	SELL	$67.19 - $87.44 $396,353 - $515,808	-5,899 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$57.54 - $76.95 $216,580 - $289,639	3,764 Added 176.3%	5,899 $408,000
Q3 2019 Nov 13, 2019	BUY	$61.55 - $75.43 $131,409 - $161,043	2,135 New	2,135 $470,000
Q2 2018 Aug 13, 2018	SELL	$42.45 - $51.3 $114,615 - $138,510	-2,700 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$37.19 - $47.45 $22,314 - $28,470	-600 Reduced 18.18%	2,700 $377,000
Q3 2017 Nov 13, 2017	BUY	$36.29 - $38.83 $36,290 - $38,830	1,000 Added 43.48%	3,300 $361,000
Q2 2017 Aug 14, 2017	BUY	N/A	2,300	2,300 $272,000

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

Stay updated on Hillsdale Investment Management Inc. with notifications on news.